Advertisement
UK markets close in 6 hours 49 minutes
  • FTSE 100

    8,109.58
    +30.72 (+0.38%)
     
  • FTSE 250

    19,796.41
    +194.43 (+0.99%)
     
  • AIM

    755.83
    +2.71 (+0.36%)
     
  • GBP/EUR

    1.1659
    +0.0003 (+0.02%)
     
  • GBP/USD

    1.2535
    +0.0024 (+0.19%)
     
  • Bitcoin GBP

    51,397.75
    +485.57 (+0.95%)
     
  • CMC Crypto 200

    1,389.39
    -7.15 (-0.51%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    83.75
    +0.18 (+0.22%)
     
  • GOLD FUTURES

    2,358.70
    +16.20 (+0.69%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,046.41
    +129.13 (+0.72%)
     
  • CAC 40

    8,039.70
    +23.05 (+0.29%)
     

Is Gene Editing Already Leaving CRISPR Therapeutics Behind?

Is Gene Editing Already Leaving CRISPR Therapeutics Behind?

Innovative companies are trying to ensure that CRISPR Therapeutics' foothold in gene editing doesn't last forever.